SEC Insider Transactions from Schoch Charles.

Last updated: 2026-03-14 11:46 UTC | Total transactions: 9

Schoch Charles sold Candel Therapeutics ($CADL) shares once on the open market in the last year, for a total of $44,169. His most recent sale occurred on March 17, 2025. These CADL insider sales rank 10,520th among nearly 12,000 individuals, well below the average of $8.6 million across about six transactions. He made no open market purchases.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Jan. 26, 2026 Candel Therapeutics, Inc. $CADL Schoch Charles Chief Financial Officer A Stock Option (Right to Buy) 232000 $0.00 232,000.0000 55,018,457 9999.99% 0.42%
June 25, 2025 Candel Therapeutics, Inc. $CADL Schoch Charles Chief Financial Officer A Common Stock 5353 $4.67 43,391.0000 46,933,088 14.07% 0.01%
June 20, 2025 Candel Therapeutics, Inc. $CADL Schoch Charles Chief Financial Officer A Stock Option (Right to Buy) 50000 $0.00 50,000.0000 46,933,088 9999.99% 0.11%
March 17, 2025 Candel Therapeutics, Inc. $CADL Schoch Charles See Remarks S Common Stock 5000 $8.83 38,038.0000 46,933,088 11.62% 0.01%
Feb. 12, 2025 Candel Therapeutics, Inc. $CADL Schoch Charles See Remarks A Stock Option (Right to Buy) 83000 $0.00 83,000.0000 46,933,088 9999.99% 0.18%
Jan. 15, 2025 Candel Therapeutics, Inc. $CADL Schoch Charles See Remarks S Common Stock 9511 $7.23 43,038.0000 46,933,088 18.10% 0.02%
Jan. 8, 2025 Candel Therapeutics, Inc. $CADL Schoch Charles See Remarks S Common Stock 9971 $8.22 52,549.0000 46,933,088 15.95% 0.02%
July 17, 2024 Candel Therapeutics, Inc. $CADL Schoch Charles See Remarks S Common Stock 9884 $6.47 62,520.0000 31,186,817 13.65% 0.03%
July 11, 2024 Candel Therapeutics, Inc. $CADL Schoch Charles See Remarks S Common Stock 8897 $5.97 72,404.0000 31,186,817 10.94% 0.03%